← All trials
NCT05232227
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 20, 2023
- Primary completion
- Jun 5, 2023
- Completion date
- Oct 30, 2023
- First posted
- Feb 9, 2022
- Last posted
- Oct 25, 2022
- Enrollment
- 428
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, San FranciscoLead sponsor
- Pan American Health OrganizationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.